Abbott, GE Healthcare ink afib deal
Abbott (NYSE:ABT) and General Electric (NYSE:GE) today said they inked a deal to integrate a pair of technologies designed to detect and map atrial fibrillation.
The deal calls for Abbott to integrate GE Healthcare’s CardioLab electrophysiology recording system into the RhythmView mapping software it acquired when it bought Topera Medical last year.
The companies claimed the combined technologies marks the 1st time physicians will be able to use instantaneous electrical heart data to diagnose atrial fibrillation sources.
“At Abbott, we are excited about collaborating with GE to help doctors more quickly diagnose the source of heart rhythm disorders with innovative technologies that combine the expertise and heritage of each company in improving patient care,” electrophysiology vice president Mike Pederson said in prepared remarks.
Abbott closes $250m Topera buyout
Abbott buys into electrophysiology with $250m Topera acquisition
David Tolan, electrophysiology global product manager for GE Healthcare, added that proper diagnosis of arrhythmias requires “intuitive, accurate, and reliable equipment.”